FI863019A - Foerfarande foer framstaellning av heterocykliska foereningar. - Google Patents

Foerfarande foer framstaellning av heterocykliska foereningar. Download PDF

Info

Publication number
FI863019A
FI863019A FI863019A FI863019A FI863019A FI 863019 A FI863019 A FI 863019A FI 863019 A FI863019 A FI 863019A FI 863019 A FI863019 A FI 863019A FI 863019 A FI863019 A FI 863019A
Authority
FI
Finland
Prior art keywords
sub
sup
alkyl
heterocykliska
foereningar
Prior art date
Application number
FI863019A
Other languages
English (en)
Other versions
FI863019A0 (fi
FI84350C (fi
FI84350B (fi
Inventor
Alexander William Oxford
Colin David Eldred
Ian Harold Coates
James Angus Bell
David Cedric Humber
George Blanch Ewan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI863019A0 publication Critical patent/FI863019A0/fi
Publication of FI863019A publication Critical patent/FI863019A/fi
Application granted granted Critical
Publication of FI84350B publication Critical patent/FI84350B/fi
Publication of FI84350C publication Critical patent/FI84350C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI863019A 1985-07-24 1986-07-23 Foerfarande foer framstaellning av heterocykliska foereningar. FI84350C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858518741A GB8518741D0 (en) 1985-07-24 1985-07-24 Process
GB8518741 1985-07-24

Publications (4)

Publication Number Publication Date
FI863019A0 FI863019A0 (fi) 1986-07-23
FI863019A true FI863019A (fi) 1987-01-25
FI84350B FI84350B (fi) 1991-08-15
FI84350C FI84350C (fi) 1991-11-25

Family

ID=10582813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863019A FI84350C (fi) 1985-07-24 1986-07-23 Foerfarande foer framstaellning av heterocykliska foereningar.

Country Status (12)

Country Link
US (1) US4739072A (fi)
EP (1) EP0219929B1 (fi)
JP (1) JPH07612B2 (fi)
KR (1) KR920001670B1 (fi)
AT (1) ATE73451T1 (fi)
CA (1) CA1281722C (fi)
DE (1) DE3684225D1 (fi)
ES (1) ES2000935A6 (fi)
FI (1) FI84350C (fi)
GB (1) GB8518741D0 (fi)
GR (1) GR861926B (fi)
PT (1) PT83043B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
US5360800A (en) * 1987-09-03 1994-11-01 Glaxo Group Limited Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives
US4939144A (en) * 1987-10-22 1990-07-03 Glaxo Group Limited Tricyclic ketone derivatives as 5-HT antagonists
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
JPH02167280A (ja) * 1988-08-15 1990-06-27 Glaxo Group Ltd ラクタム誘導体
AU631632B2 (en) 1989-04-21 1992-12-03 Novartis Ag Therapeutic use of 5-ht3 receptor antagonists
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
CN1498216A (zh) * 2000-10-30 2004-05-19 ������ҩ��ҵ���޹�˾ 新的奥丹西隆盐酸盐晶体和溶剂化物及其制备方法
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
US7098345B2 (en) * 2002-04-29 2006-08-29 TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20090170872A1 (en) * 2005-07-05 2009-07-02 Orchid Research Laboratories Limited Compounds and Their Pharmaceutical Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
US3892766A (en) * 1974-06-03 1975-07-01 Warner Lambert Co Process for the preparation of 4-keto-1,2,3,4-tetrahydrocarbazole
GR73560B (fi) * 1979-02-24 1984-03-15 Pfizer
EP0073849A1 (en) * 1981-09-03 1983-03-16 Schering Corporation Novel phenyl-1,2,3,4-tetrahydrocarbazoles, their preparation and pharmaceutical compositions containing them
CH664152A5 (fr) * 1984-01-25 1988-02-15 Glaxo Group Ltd Derives de tetrahydrocarbazolones.

Also Published As

Publication number Publication date
CA1281722C (en) 1991-03-19
GR861926B (en) 1986-09-05
GB8518741D0 (en) 1985-08-29
FI863019A0 (fi) 1986-07-23
JPH07612B2 (ja) 1995-01-11
US4739072A (en) 1988-04-19
DE3684225D1 (de) 1992-04-16
KR870001198A (ko) 1987-03-12
FI84350C (fi) 1991-11-25
EP0219929B1 (en) 1992-03-11
JPS6277380A (ja) 1987-04-09
FI84350B (fi) 1991-08-15
PT83043B (pt) 1989-02-28
ES2000935A6 (es) 1988-04-01
ATE73451T1 (de) 1992-03-15
KR920001670B1 (ko) 1992-02-22
EP0219929A1 (en) 1987-04-29
PT83043A (en) 1986-08-01

Similar Documents

Publication Publication Date Title
FI863019A0 (fi) Foerfarande foer framstaellning av heterocykliska foereningar.
FI863020A0 (fi) Foerfarande foer framstaellning av heterocykliska foereningar.
DE69021502D1 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und Anwendung.
IE881927L (en) Anellated indole derivatives
EP0269574A3 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
MY109737A (en) Treatment and compounds.
FI842987A (fi) Nya 1,8-naftyridin-derivat och foerfaranden foer deras framstaellning.
AU546057B2 (en) Dihydropyridine derivatives
ATE57919T1 (de) Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide.
EP0371805A3 (en) Piperidine derivatives and hypotensives containing the same
DE69828284D1 (de) Naphthyridinderivate oder salze davon
EP0356098A3 (en) Lactam derivatives
EP0327307A3 (en) Tricyclic ketone derivatives having a 5-HT3 antagonist activity
DE3788149T2 (de) Prostazyklin-(PGI2)-Analoge.
HUT37756A (en) Process for preparing 1,4-dihydro-pyridina derivatives
DE68922287D1 (de) Imidazol und Pyridyl-Derivate von Phenyl substituierten 1,4-Dihydropyridinen und Verfahren zu ihrer Herstellung.
ATE102610T1 (de) Imidazolderivate, verfahren zu deren herstellung und diese enthaltende antiulkusmittel.
ES8200661A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina
TH3248A (th) อนุพันธ์ของกรด n-ซับสทิทิวเทดอะมิโน โพรเพนซัลโฟนิค
MY104164A (en) Heterocyclic compounds.
TH3248EX (th) อนุพันธ์ของกรด n-ซับสทิทิวเทดอะมิโน โพรเพนซัลโฟนิค

Legal Events

Date Code Title Description
FG Patent granted

Owner name: GLAXO GROUP LIMITED

MA Patent expired